Apimeds Pharmaceuticals US, Inc. (APUS) Net income 2023–2025
Apimeds Pharmaceuticals US, Inc. (APUS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.0MFY2025 · since FY2023: -$777,694 → -$6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.0M | -331.7% |
| FY2024 | -$1.4M | -78.7% |
| FY2023 | -$777,694 | — |
Source: SEC XBRL filings · For reference only · Not investment advice